Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $47,534 | 43 | 33.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40,250 | 17 | 28.2% |
| Food and Beverage | $28,310 | 960 | 19.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $10,308 | 6 | 7.2% |
| Travel and Lodging | $9,338 | 37 | 6.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,664 | 5 | 4.7% |
| Education | $300.72 | 8 | 0.2% |
| Entertainment | $145.13 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $68,175 | 467 | $0 (2024) |
| Medtronic, Inc. | $51,068 | 204 | $0 (2024) |
| BIOTRONIK NRO, Inc. | $11,983 | 42 | $0 (2024) |
| Vertiflex, Inc. | $2,057 | 10 | $0 (2019) |
| Boston Scientific Corporation | $1,741 | 70 | $0 (2024) |
| Nevro Corp. | $1,322 | 26 | $0 (2024) |
| Nalu Medical, Inc. | $789.78 | 24 | $0 (2024) |
| ABBVIE INC. | $755.33 | 32 | $0 (2024) |
| PAINTEQ LLC | $652.33 | 27 | $0 (2024) |
| Medtronic USA, Inc. | $487.67 | 17 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,348 | 184 | Medtronic, Inc. ($26,414) |
| 2023 | $23,923 | 172 | Medtronic, Inc. ($22,330) |
| 2022 | $6,455 | 156 | Medtronic, Inc. ($2,178) |
| 2021 | $5,295 | 106 | Abbott Laboratories ($4,421) |
| 2020 | $9,086 | 111 | Abbott Laboratories ($8,537) |
| 2019 | $11,037 | 153 | Abbott Laboratories ($8,014) |
| 2018 | $28,129 | 112 | Abbott Laboratories ($27,579) |
| 2017 | $18,576 | 83 | Abbott Laboratories ($17,123) |
All Payment Transactions
1,077 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/17/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,362.50 | General |
| Category: Not Applicable | ||||||
| 12/17/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,100.00 | General |
| Category: Not Applicable | ||||||
| 11/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.02 | General |
| 11/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.24 | General |
| 11/18/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: Not Applicable | ||||||
| 11/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.02 | General |
| 11/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.93 | General |
| 11/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/02/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Not Applicable | ||||||
| 11/02/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: Not Applicable | ||||||
| 11/01/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: Opioid Analgesic | ||||||
| 10/24/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $29.42 | General |
| 10/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/19/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Not Applicable | ||||||
| 10/15/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Not Applicable | ||||||
| 10/15/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/15/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Drug Infusion Systems | ||||||
| 10/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Vision Quest Industries Inc. | Avid CT2 NMES/IFC STIMULATOR (Device), OACTIVE ALIGN CUSTOM R | Food and Beverage | In-kind items and services | $52.41 | General |
| Category: NMES/IF | ||||||
| 10/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Gastroenterology | ||||||
| 10/06/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $132.77 | General |
| Category: Not Applicable | ||||||
| 10/05/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Travel and Lodging | In-kind items and services | $414.90 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,328 | 2,786 | $1.2M | $192,197 |
| 2022 | 22 | 1,530 | 3,394 | $1.4M | $226,709 |
| 2021 | 26 | 1,485 | 3,660 | $1.9M | $252,568 |
| 2020 | 21 | 1,188 | 2,100 | $1.3M | $167,653 |
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 377 | 841 | $359,107 | $81,861 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 271 | 652 | $197,556 | $43,106 | 21.8% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 194 | 328 | $49,200 | $10,703 | 21.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $44,240 | $9,333 | 21.1% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 13 | 33 | $280,698 | $8,500 | 3.0% |
| J3490 | Unclassified drugs | Office | 2023 | 19 | 68 | $32,870 | $8,447 | 25.7% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 20 | 77 | $36,868 | $5,169 | 14.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 80 | $15,200 | $3,696 | 24.3% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 23 | 65 | $13,585 | $3,202 | 23.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 13 | 19 | $29,925 | $3,012 | 10.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 25 | 38 | $34,998 | $2,978 | 8.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 26 | 28 | $17,108 | $2,931 | 17.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 13 | 18 | $10,206 | $2,154 | 21.1% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 19 | 20 | $11,340 | $1,797 | 15.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 26 | 28 | $8,736 | $1,681 | 19.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $4,476 | $1,012 | 22.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 13 | 19 | $16,796 | $917.00 | 5.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 62 | 94 | $16,826 | $909.81 | 5.4% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 13 | 26 | $1,612 | $353.05 | 21.9% |
| 20550 | Injection into tendon or ligament | Facility | 2023 | 11 | 11 | $2,123 | $237.71 | 11.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 50 | 249 | $2,490 | $196.74 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 379 | 1,122 | $432,833 | $74,389 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 248 | 379 | $201,245 | $35,172 | 17.5% |
| J3490 | Unclassified drugs | Office | 2022 | 24 | 91 | $51,880 | $28,404 | 54.7% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2022 | 198 | 396 | $92,635 | $12,887 | 13.9% |
About Dr. Marc Lynch, D.O
Dr. Marc Lynch, D.O is a Pain Medicine healthcare provider based in Chino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760488621.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Lynch, D.O has received a total of $142,849 in payments from pharmaceutical and medical device companies, with $40,348 received in 2024. These payments were reported across 1,077 transactions from 60 companies. The most common payment nature is "Consulting Fee" ($47,534).
As a Medicare-enrolled provider, Lynch has provided services to 5,531 Medicare beneficiaries, totaling 11,940 services with total Medicare billing of $839,127. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Chino, CA
- Active Since 06/24/2005
- Last Updated 06/10/2024
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760488621
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $34,031
- Proclaim Family of SCS IPGs (Device) $23,176
- Prospera (Device) $11,966
- Axium INS DRG IPG (Device) $10,882
- SCS IPGs (Device) $10,194
- KYPHON EXPRESS II KYPHOPAK TRAY (Device) $8,051
- SCS leads (Device) $7,028
- Neuromodulation Dspsbls and Accs (Device) $6,759
- SYNCHROMEDII (Device) $6,003
- VANTA ADAPTIVESTIM (Device) $2,467
- DRG IPGs (Device) $2,250
- PROCLAIM (Device) $2,134
- Superion ISS (Device) $2,057
- Proclaim DRG IPG (Device) $1,925
- Proclaim IPG (Device) $1,642
- BOTOX (Biological) $789.83
- Nalu Neurostimulation System (Device) $789.78
- IonicRF Generator (Device) $770.00
- PAINTEQ (Device) $652.33
- Senza Spinal Cord Stimulation System (Device) $628.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.